Stock Comparison
ABBV vs NVO
AbbVie Inc and Novo Nordisk A/S side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$212.80B
P/E (TTM)
123.6
11.6
Forward P/E
17.8
14.3
Price/Sales
7.1
0.7
Price/Book
50.5
6.9
EV/EBITDA
30.2
8.5
Dividend Yield
2.77%
3.75%
Profitability
Net Margin
5.79%
37.20%
Operating Margin
32.20%
61.60%
Return on Equity
62.30%
71.40%
Return on Assets
10.00%
19.30%
Growth (YoY)
Revenue Growth
12.40%
24.00%
Earnings Growth
-46.20%
67.10%
Price & Risk
Beta
0.3
0.3
52-Week High
$253.35
$68.49
52-Week Low
$176.02
$34.58
Analyst Target
$254.38
$46.86
Compare ABBV and NVO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.